Mattress Vibration and Nitric Oxide Boost Brain Clearance
A small study found the combined approach increased clearance of an Alzheimer's-related protein, and a 60-person trial is planned next year.
Updated on Nov. 3, 2026 in Alzheimer’s
Live Poll
Would you try a vibrating mattress or supplement to support brain health?
Scientists presented a method combining a vibrating mattress with nitric oxide pills that enhanced glymphatic clearance of an Alzheimer's-related protein. The approach was tested in 29 adults who had not been diagnosed with Alzheimer's disease or other cognitive issues.
Why it matters
The glymphatic system clears waste from the brain, and its impairment is linked to Alzheimer's, so a non-drug approach that improves clearance offers a new line of research. The results remain preliminary and come from a small group without the disease.
The study measured blood beta-amyloid 42, which rose 35 per cent on average across 29 adults, while solo interventions produced less than half the glymphatic effect of the combined approach. Whether these changes lead to cognitive benefit in people with Alzheimer's has not been tested.
The players
Kiviniemi
Kiviniemi is a researcher at the University of Oulu in Finland who led the study on vibration and nitric oxide and the glymphatic system.
University of Oulu
The University of Oulu is a public research university in Finland that hosts the lead researcher's work on brain clearance.
University of Southampton
The University of Southampton is a research university in the United Kingdom whose academic Brown offered outside commentary on the findings.
The details
Participants lay on a mattress that vibrated their bodies for 40 minutes while taking a pill that dissolves under the tongue and releases nitric oxide. Vibration activates the Piezo1 protein in blood vessel muscle cells, while nitric oxide dilates brain vessels and narrows glymphatic channels, increasing pressure on waste fluid.
Timeline
November 3, 2026: Latest research on the vibrating mattress and nitric oxide approach was presented.
Next year: A trial of the combined approach is planned in 60 people with mild cognitive impairment or Alzheimer's disease.
Following two years: Possible results from the planned 60-person trial could emerge.
Health Landscape
Research into the glymphatic system, which clears waste from the brain during sleep and rest, has grown as scientists test whether impaired clearance contributes to Alzheimer's. This study adds a non-drug approach to a field that has so far relied largely on pharmaceutical and lifestyle interventions.
Readers with memory concerns should not expect this approach to be available outside research settings, since it has only been tested in a small group without the disease. Any decision about treatment should be made with a clinician, particularly given reported side effects such as nausea and headache.
The takeaway
Early findings suggest that improving brain waste clearance may be a route to studying Alzheimer's, but the evidence is limited to a small group. Larger trials in people with cognitive impairment will determine whether the approach has any meaningful benefit.
What happens next
A trial of the combined approach in 60 people with mild cognitive impairment or Alzheimer's disease is planned for next year.
Further reading
Explore more on Alzheimer’s research and treatment developments.
Live Poll
Would you try a vibrating mattress or supplement to support brain health?
